FDA flags potential cardiac risk with evenamide - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA flags potential cardiac risk with evenamide

Four deaths among evenamide-treated patients prompted FDA concerns about possible fatal arrhythmias, although a causal link remains unconfirmed.

  • By

  • Mouj Hijazi

  • October 8, 2026

  • 3 min

Share

Original Source(s)

FDA flags potential cardiac risk with evenamide

  • by Mouj Hijazi

  • October 8, 2026

Related Content

Failure to Update ClinicalTrials.gov Record for a Clinical Trial

Medical Oddities: Alive, but convinced otherwise

A deadly conviction, healing vanilla, stormy lungs, and a COVID tea party await.

36 genes may reshape OCD, tic genetics

Whole-exome sequencing identifies large-effect risk genes across obsessive-compulsive and chronic tic disorders, with most supported by both conditions.